Heru Sasongko^1* , Aulia Hanundita Maharani¹ , Joshua Arianto Hutasoit¹ , Darmawan Lahru Riatma² , Hardian Ningsih³ , Sritrusta Sukaridhoto⁴ , Mohammad Robihul Mufid⁴ , MH. Ramdhani Ismar⁵ , Ardian Prima Atmaja⁵ , Alfi Tranggono Agus Salim⁵  and Ronny Martien⁶

¹Department of Pharmacy, Vocational School, Sebelas Maret University, Central Java, Indonesia.

²Department of Informatic Engineering, Vocational School, Sebelas Maret University, Central Java, Indonesia.

³Department of Agribusiness, Vocational School, Sebelas Maret University, Surakarta, Central Java, Indonesia.

⁴Department of Informatic Engineering and Computer, Politeknik Elektronika Negeri Surabaya, Jl. Raya ITS, Sukolilo, Surabaya, East Java, Indonesia.

⁵Department of Informatic Engineering and Computer, Politeknik Negeri Madiun, Taman, Pandean, Madiun City, East Java, Indonesia.

⁶Department of Pharmaceutics, Faculty of Pharmacy, Universitas of Gadjah Mada, Yogyakarta, Indonesia.

Corresponding Author E-mail: heru_sasongko@staff.uns.ac.id

Abstract

Turmeric (Curcuma longa) are known to contain curcumin, a lipophilic polyphenol from the curcuminoid group. Curcumin has been used for generations in traditional medicine, due to antioxidant, anti-inflammatory, hepatoprotective, cardio-protective, antimicrobial, nephroprotective, immunomodulatory, hypoglycemic, anti-rheumatic, anti-cancer, and anti-fibrotic properties. Therefore, this study aimed to determine pharmacological activity potential of curcumin using selected test parameters. Several journals were collected from PubMed, Scopus, and Science Direct for this review, limiting the time frame to the last 8 years. The findings are then presented in the form of figures and tables, followed by a full discussion based on the appropriate reference. The results showed that curcumin had antioxidant and anti-inflammatory effects. These effects contributed to various mechanisms of action in numerous diseases, including cardiovascular, anti-cancer, arthritis, brain injury, Alzheimer's, digestive disorders, anti-aging, and hepatoprotection. Several external factors that influenced test results included curcumin dosage, duration of administration, and pain- or disease-inducing ingredients. In long-term therapy with certain drugs, the administration of curcumin could be considered at the right dose to avoid dangerous side effects.

Keywords

Antioxidant; Anti-Inflammatory; Curcumin; Pharmacological Activity; Rhizomes

Copy the following to cite this article: Sasongko H, Maharani A. H, Hutasoit J. A, Riatma D. L, Ningsih H, Sukaridhoto S, Mufid M. R, Ismar M. H. R, Atmaja A. P, Salim A. T. A, Martien R. An Updated Review of Curcumin in Health Applications: In-vivo Studies and Clinical Trials. Biomed Pharmacol J 2024;17(4).

Copy the following to cite this URL: Sasongko H, Maharani A. H, Hutasoit J. A, Riatma D. L, Ningsih H, Sukaridhoto S, Mufid M. R, Ismar M. H. R, Atmaja A. P, Salim A. T. A, Martien R. An Updated Review of Curcumin in Health Applications: In-vivo Studies and Clinical Trials. Biomed Pharmacol J 2024;17(4). Available from: https://bit.ly/49qBXmo

Introduction

Several medicinal plants, including rhizomes of turmeric (Curcuma longa), ginger (Curcuma xanthorrhiza), and red ginger (Zingiber officinale Var. Rubrum), are known to contain curcumin, also referred to as diferuloylmethane (1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione). This compound is a lipophilic polyphenol belonging to the curcumionide group. Numerous in vitro and in vivo studies have demonstrated biological and pharmacological effects of curcumin, making it a viable alternative herbal medicine for diseases such as asthma and liver damage. The various functions can be attributed to antioxidant, anti-inflammatory, hepatoprotective, cardio-protective, antimicrobial, nephroprotective, immunomodulatory, hypoglycemic, anti-rheumatic, anti-cancer, and anti-fibrotic properties ^1,2.

Studies on pharmacological effects of curcumin have produced both positive and negative results. Several tests related to curcumin activity have produced different effects ³. The test group given low-dose curcumin showed positive results in all hepatoprotective test parameters. The amounts of SOD (superoxide dismutase) and MDA (malondialdehyde), which helped lower oxidative stress, did not change in the test group given high doses of curcumin. Some researchers report a study on a population of type 2 diabetes patients, and the results found no change in the hs-CRP (high-sensitivity C-reactive protein) test parameters ⁴. Therefore, this study aimed to explore the therapeutic or placebo effects of curcumin on various diseases. This review was conducted on the latest literature on clinical trials and animal studies to provide updated information. Additionally, it talks about the outcomes of tests that don’t support the hypothesis or samples that don’t have significant effects.

Materials and Methods

In this review, several journals were collected from PubMed, Scopus, and Science Direct with a maximum limit of the last 8 years. The keywords used include curcuminoid, hepatoprotective, liver, and curcumin health benefits. Furthermore, only English-language journals or publications offering open access were used. The inclusion criteria include (a) clinical studies that examined the role of curcuminoid in health benefits; (b) pharmacological activity of active curcuminoid compounds in living organisms; and (c) the possible pharmacological effects of active curcuminoid on hepatoprotective factors and health benefits. The findings are then presented in the form of figures and tables, followed by a full discussion based on the appropriate reference.

Results and Discussion

Active Curcuminoid Compounds

Curcumin is a natural yellow hydrophobic polyphenolic pigment that is insoluble in water. This active compound is found in several medicinal plants used in traditional medicines [Figure 1]. Studies have showed pharmacological effects of curcumin, manifesting as antioxidants and anti-inflammatory agents, through mechanisms including alterations in gene expression and cellular signaling ⁵. Turmeric, or kencur [Figure 1], is a plant native to India and widely cultivated in areas with temperatures between 20^◦C-35^◦C and high rainfall, such as Indonesia ^6,7.

Rhizomatous roots are specifically collected at the end of the vegetative phase when the plant can produce therapeutic effects. For decades, several chemical compounds found in ginger have been studied, including oxygenated sesquiterpenes, monoterpenes, and curcuminoid derivative compounds such as curcumin, bisdemethoxycurcumin, and demethoxycurcumin ^6,8.

Figure 1: Medicinal plants containing active curcuminoid compounds   Click here to view Figure

 

Pharmacological Activity of Curcuminoid Compounds for Health

Studies on the active compound curcumin have increased in the last few decades due to the therapeutic potential, which spans almost all parts of the human body. Other functions include antioxidant, anti-inflammatory, human immune regulatory system, antidiates, nervous system protector, cardiovascular system protector, anticancer ^9–11, arthritis, brain injury, Alzheimer’s, anti-aging, and hepatoprotective effects ¹²,¹³,¹⁴,¹⁵,¹⁶. Pharmacological activities reported in the reviewed studies are shown in [Figure 2].

Figure 2: The role of curcuminoid in health for all parts of the human body     Click here to view Figure

 

Recent clinical and in vivo tests have been carried out to show the emergence of pharmacological effects of curcumin. Specifically, studies have tested curcumin under predetermined protocols with a wide variety of doses, populations, and groups of animals. Empirical studies assert that plants contain curcumin, a compound with the potential to cure all diseases. This result became the basis for studies developing the effects of curcumin in almost every part of the human body, with varying degrees of success. Furthermore, numerous in vivo investigations and clinical trials have been conducted. Tables 1 and 2 show the numerous in vivo studies and clinical trials in sick populations.

Table 1: In vivo studies on active curcuminoid compounds.

Active Compounds	Test Animal Group	Dose	Measured parameters	Reference
Curcumin	32 adult male Wistar rats (200-250 gr)	100 mg/kg/day for 28 days orally.	↓ALP, ↓ASP, ↓ALT	17
Curcumin and the Curcumin Phytosome	50 male mice (25-30 g)	100-200 mg/kg body weight orally.	Groups III and IV ↑MDA, ↓SOD, ↓CAT and ↓GPx.   Group V ↓MDA, ↑SOD, ↑CAT and ↑GPx	18
Curcumin + dimethylnitrosamine	32 Adult male Wistar rats (260~280 g).	100 mg/kg body weight orally.	Group III ↓AST, ↓ALT, and ↓ALB Group IV ↓AST, ↓ALT, and ↓ALB	19
Curcumin	66 Adult male Wistar rats (180-200 g).	100-200 mg/kg body weight orally.	Group III ↓ALT, ↓AST, ↓AFP, ↓albumin concentration, ↓MDA and ↑SOD Group IV ↓ALT, ↓AST, ↓AFP, ↑albumin concentration, ↔ MDA and ↔ SOD, ↑hepatic lobule physique	20
Curcumin + BPA	42 Adult male Wistar rats (250–300 g)	100-130 mg/kg body weight orally.	Group III ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST Group IV ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST Group V ↑MDA, ↓SOD, ↓CAT, ↓GPx and ↓GST Group VI ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST Group VII ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST	21
Curcumin + Paraquat (PQ)	36 Adult male Wistar rats (220–250 g)	100 mg/kg body weight orally.	Group V ↓ALT, ↓AST, ↓ALP and ↓MDA Group VI ↓ALT, ↓AST, ↓ALP and ↓MDA	22
Curcumin	24 adult male Wistar rats	Curcumin 50 mg/kg body weight for 12 weeks orally.	Group IV (first phase) and Group III (second phase) ↓fibrosis, ↓liver biomarkers, ↑CAT, ↑SOD, ↑GSH, ↑electrolyte homeostasis	23
Curcumin	25 adult male Wistar rats (250-280 grams)	10-50 mg/kg body weight, intraperitoneally for 5 weeks.	↓NLRP3, IL-1β, IL-6, IL-18, TNF-α ↑BDNF/TrkB, PI3K/Akt signaling pathways	24
Curcumin	30 adult male Wistar rats (180-200 grams)	300 mg/kg body weight orally for 4 weeks.	↓Serum creatinine, ↓urine albumen, and ↓urea nitrogen enhanced E-cadherin, ↓LC3 proteins expression, ↓p62, ↓phosphorylated levels of Akt, ↓mTOR, and ↓P13K levels	25
Curcumin	30 adult male Wistar rats (200-220 grams)	15-60 mg/kg body weight, through oral gavage.	↓Inflammation via up-regulating miR-200a-mediated TXNIP and ↓NLRP3 inflammasome pathway	26
Curcumin	48 adult male Wistar rats (230-250 grams)	200 mg/kg body weight orally.	↓Inflammation by downregulation of ↓TNFa, ↓IL1b, and ↓IL 6 Blocked TLR4 /MyD88/NFkB signal pathways	27

↓significantly decreased, ↑ significantly increased, ↔ showed no effect (still)

Table 2: Clinical Trial of active curcuminoid compounds

Active Compounds	Test Animal Group	Dose	Measured parameters	Reference
Curcumin	32 adult male Wistar rats (200-250 gr)	100 mg/kg/day for 28 days orally.	↓ALP, ↓ASP, ↓ALT	17
Curcumin and the Curcumin Phytosome	50 male mice (25-30 g)	100-200 mg/kg body weight orally.	Groups III and IV ↑MDA, ↓SOD, ↓CAT and ↓GPx. Group V ↓MDA, ↑SOD, ↑CAT and ↑GPx	18
Curcumin + dimethylnitrosamine	32 Adult male Wistar rats (260~280 g).	100 mg/kg body weight orally.	Group III ↓AST, ↓ALT, and ↓ALB Group IV ↓AST, ↓ALT, and ↓ALB	19
Curcumin	66 Adult male Wistar rats (180-200 g).	100-200 mg/kg body weight orally.	Group III ↓ALT, ↓AST, ↓AFP, ↓albumin concentration, ↓MDA and ↑SOD Group IV ↓ALT, ↓AST, ↓AFP, ↑albumin concentration, ↔ MDA and ↔ SOD, ↑hepatic lobule physique	20
Curcumin + BPA	42 Adult male Wistar rats (250–300 g)	100-130 mg/kg body weight orally.	Group III ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST Group IV ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST Group V ↑MDA, ↓SOD, ↓CAT, ↓GPx and ↓GST Group VI ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST Group VII ↓MDA, ↑SOD, ↑CAT, ↑GPx and ↑GST	21
Curcumin + Paraquat (PQ)	36 Adult male Wistar rats (220–250 g)	100 mg/kg body weight orally.	Group V ↓ALT, ↓AST, ↓ALP and ↓MDA   Group VI ↓ALT, ↓AST, ↓ALP and ↓MDA	22
Curcumin	24 adult male Wistar rats	Curcumin 50 mg/kg body weight for 12 weeks orally.	Group IV (first phase) and Group III (second phase)   ↓fibrosis, ↓liver biomarkers, ↑CAT, ↑SOD, ↑GSH, ↑electrolyte homeostasis	23
Curcumin	25 adult male Wistar rats (250-280 grams)	10-50 mg/kg body weight, intraperitoneally for 5 weeks.	↓NLRP3, IL-1β, IL-6, IL-18, TNF-α ↑BDNF/TrkB, PI3K/Akt signaling pathways	24
Curcumin	30 adult male Wistar rats (180-200 grams)	300 mg/kg body weight orally for 4 weeks.	↓Serum creatinine, ↓urine albumen, and ↓urea nitrogen enhanced E-cadherin, ↓LC3 proteins expression, ↓p62, ↓phosphorylated levels of Akt, ↓mTOR, and ↓P13K levels	25
Curcumin	30 adult male Wistar rats (200-220 grams)	15-60 mg/kg body weight, through oral gavage.	↓Inflammation via up-regulating miR-200a-mediated TXNIP and ↓NLRP3 inflammasome pathway	26
Curcumin	48 adult male Wistar rats (230-250 grams)	200 mg/kg body weight orally.	↓Inflammation by downregulation of ↓TNFa, ↓IL1b, and ↓IL 6 Blocked TLR4 /MyD88/NFkB signal pathways	27

↓significantly decreased, ↑ significantly increased, ↔ showed no effect (still)

Antioxidant Effect

Antioxidant activity of curcumin is one of the several protective mechanisms. Oxidative stress is a supporting factor for damage to important organs in the body ⁴². All cells, both animal and human, require oxygen for normal function to form ATP, which the body then converts into energy through metabolic processes. However, reactive oxygen species, which play a role in liver damage, can transfer oxygen into toxic compounds. During the aerobic respiration process, the production of free radicals potentially causes aging and cell death ⁴³.

Mitochondria reduce oxygen molecules to produce superoxide or peroxide ions (H2O2), a free radical ⁴⁴. Superoxide and peroxide then react with metal ions and produce hydroxyl radicals. Subsequently, hydroxyl radicals react with cell components, including DNA and proteins, which can induce damage to the liver ⁴⁵. The therapeutic potential of polyphenols in curcumin is often associated with antioxidant properties, which are able to capture free radicals such as superoxide or peroxide ions (H2O2). According to a study, curcumin contains 10 times more antioxidants than vitamin E ⁴³.

The active curcumin compound, with antioxidant effect, effectively binds free radicals and provides hydrogen atoms. Based on chemical structure, the phenolic hydroxyl group (an electron-donating group) is the main part that makes curcumin an antioxidant ^11,46. In hyperlipidemia disorders, the administration of curcumin can reduce the incidence of cardiovascular complications ^47,48.

Anti-inflammatory Agent

During tissue damage from oxidative stress or other factors, inflammation is a response that starts a chain of events leading to repair processes, such as extracellular matrix reform and fibrosis ⁴⁹. Chronic inflammation is defined as macrophage inflammation through tissue invasion and can last for several months to years ⁵⁰. However, curcumin can turn on PPAR-gamma (Peroxisome Proliferator-Activated Receptor-gamma) and stop the production of pro-inflammatory cytokines such as TNF-alpha and interleukin-1β by blocking signaling pathways including Nf-kβ (Factor Nuclear kappa-β) [Figure 3] ⁵¹. The invasion process of curcumin triggers the expression of inflammatory cytokines or growth factors, closely associated with the pathophysiology of various diseases and lifestyles such as cardiovascular disease, obesity, diabetes, myocarditis, dementia, atherosclerotic, chronic obstructive pulmonary disease, and other conditions ⁴⁹,⁵²,⁵³. In type 2 diabetes patients, curcumin potentially raises lipid metabolism with a decrease in leptin and an increase in adiponectin levels in the blood ^30,54,55. The findings of this research provide more thorough data on the relationship between curcumin dosages and many blood biochemical markers, inflammation, and antioxidants. Research on humans and experimental animals yields almost identical results, however other investigations showed no significant impacts. In previous studies, there was not much discussion of the parameters that were affected by the use of curcumin.

Figure 3: Potential mechanism of curcumin in anti-inflammation activity and lifestyle-related conditions (COX2 = cyclooxygenase-2; mPGES-1 = microsomal prostaglandin E synthase-1) 55.   Click here to view Figure

 

Conclusion

In conclusion, various studies, both in vivo and clinical, on the test populations in this review showed that curcumin had pharmacological activity in various diseases. The polyphenolic compound had therapeutic potential attributed to the antioxidant properties that could capture free radicals. In hypercholesterolemia conditions, antioxidant activity reduced enzymes, which had a major effect on oxidative stress in the liver. Additionally, studies demonstrated anti-inflammatory activity of curcumin, which contributed to the mechanism of action in various diseases. The future prospectives of curcumin in health applications can be developed in various pharmaceutical preparations, such as nanoparticles, which have the potential to provide higher effects. Comprehensive clinical trials and the potential for drug interactions with other substances molecularly need further research.

Acknowledgement

The author would like to thank the consortium team from Universitas Sebelas Maret, Politeknik Elektronika Negeri Surabaya, and Politeknik Negeri Madiun for their collaboration in the research grant assignment from the Ministry of Education, Culture, Research, and Technology, Indonesia.

Funding Sources

This research was funded by Ministry of Education, Culture, Research, and Technology, Indonesia, Directorate General of Vocational Education with the Applied Research Assignment scheme number: 37/SPK/D.D4/PPK.01.APTV /III/2024 and sub-contract number: 231.1/UN27.22/PT.01.03/2024  with a contract on behalf of Heru Sasongko.

Conflict of Interest

The author(s) do not have any conflict of interest

Data Availability Statement

This statement does not apply to this article

Ethics Statement

This research did not involve human participants, animal subjects, or any material that requires ethical approval.

Informed Consent Statement

This study did not involve human participants, and therefore, informed consent was not required.

Author Contributions

Heru Sasongko : Conceptualization, Methodology, Supervision

Aulia Hanundita Maharani : Data Collection, Writing – Original Draft

Joshua Arianto Hutasoit : Data Collection, Analysis

Darmawan Lahru Riatma : Editing

Hardian Ningsih : Project Administration

Sritrusta Sukaridhoto : Supervision

Mohammad Robihul Mufid : Editing

MH. Ramdhani Ismar : Project Administration

Ardian Prima Atmaja : Editing

Alfi Tranggono Agus Salim: Visualization

Ronny Martien : Supervision

References

1. Alagawany M, Farag MR, Abdelnour SA, Dawood MAO, Elnesr SS, Dhama K. Curcumin and its different forms: A review on fish nutrition. Aquaculture. 2021;532:736030.
   CrossRef
2. Ghoreshi Z al sadat, Kabirifar R, Safari F, Karimollah A, Moradi A, Eskandari-Nasab E. Hepatoprotective effects of curcumin in rats after bile duct ligation via downregulation of Rac1 and NOX1. Nutrition. 2017;36:72-78.
   CrossRef
3. Elmansi AM, El-Karef AA, El-Shishtawy MM, Eissa LA. Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways. Annals of Hepatology. 2017;16(4):607-618.
   CrossRef
4. Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian MS, Majeed M, Sahebkar A. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacol. 2017;25(1):25-31.
   CrossRef
5. Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325-1348.
   CrossRef
6. Micucci M, Budriesi R, Mandrioli M, Tura M, Corazza I, Frosini M, Aldini R, Mattioli LB, Gallina Toschi T. Effects of turmeric powder on intestinal and biliary functions: The influence of curcuminoids concentration on spontaneous contractility. Journal of Functional Foods. 2022;99:105314.
   CrossRef
7. Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19(12):20091-20112.
   CrossRef
8. Serpa Guerra AM, Gómez Hoyos C, Velásquez-Cock JA, Vélez Acosta L, Gañán Rojo P, Velásquez Giraldo AM, Zuluaga Gallego R. The nanotech potential of turmeric (Curcuma longa L.) in food technology: A review. Crit Rev Food Sci Nutr. 2020;60(11):1842-1854.
   CrossRef
9. Cao J, Wang T, Wang M. Investigation of the anti-cataractogenic mechanisms of curcumin through in vivo and in vitro studies. BMC Ophthalmol. 2018;18(1):48.
   CrossRef
10. Wang R, Li J, Zhao Y, Li Y, Yin L. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis. Breast Cancer. 2018;25(2):206-212.
    CrossRef
11. Xu XY, Meng X, Li S, Gan RY, Li Y, Li HB. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients. 2018;10(10):1553.
    CrossRef
12. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – A review. Journal of Traditional and Complementary Medicine. 2017;7(2):205-233.
    CrossRef
13. Gopi S, Jacob J, Varma K, Jude S, Amalraj A, Arundhathy C a., George R, Sreeraj T r., Divya C, Kunnumakkara AB, Stohs SJ. Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study. Phytotherapy Research. 2017;31(12):1883-1891.
    CrossRef
14. Hussain Z, Thu HE, Ng SF, Khan S, Katas H. Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: A review of new trends and state-of-the-art. Colloids and Surfaces B: Biointerfaces. 2017;150:223-241.
    CrossRef
15. Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. British Journal of Pharmacology. 2017;174(11):1325-1348.
    CrossRef
16. Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomedicine & Pharmacotherapy. 2017;85:102-112.
    CrossRef
17. Ghoreshi Z al sadat, Kabirifar R, Safari F, Karimollah A, Moradi A, Eskandari-Nasab E. Hepatoprotective effects of curcumin in rats after bile duct ligation via downregulation of Rac1 and NOX1. Nutrition. 2017;36:72-78.
    CrossRef
18. Tung BT, Hai NT, Son PK. Hepatoprotective effect of Phytosome Curcumin against paracetamol-induced liver toxicity in mice. Braz J Pharm Sci. 2017;53.
    CrossRef
19. Kyung EJ, Kim HB, Hwang ES, Lee S, Choi BK, Kim J woong, Kim HJ, Lim SM, Kwon OI, Woo EJ. Evaluation of Hepatoprotective Effect of Curcumin on Liver Cirrhosis Using a Combination of Biochemical Analysis and Magnetic Resonance-Based Electrical Conductivity Imaging. Mediators of Inflammation, 2018, 2018(1): 5491797.
    CrossRef
20. Elmansi AM, El-Karef AA, El-Shishtawy MM, Eissa LA. Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways. Annals of Hepatology. 2017;16(4):607-618.
    CrossRef
21. Uzunhisarcikli M, Aslanturk A. Hepatoprotective effects of curcumin and taurine against bisphenol A-induced liver injury in rats. Environ Sci Pollut Res. 2019;26(36):37242-37253.
    CrossRef
22. Kheiripour N, Plarak A, Heshmati A, Asl SS, Mehri F, Ebadollahi-Natanzi A, Ranjbar A, Hosseini A. Evaluation of the hepatoprotective effects of curcumin and nanocurcumin against paraquat-induced liver injury in rats: Modulation of oxidative stress and Nrf2 pathway. J Biochem Mol Toxicol. 2021;35(5):e22739.
    CrossRef
23. Zaidi SNF, Mahboob T. Hepatoprotective role of curcumin in rat liver cirrhosis. Pak J Pharm Sci. 2020;33(4):1519-1525.
24. Sun G, Miao Z, Ye Y, Zhao P, Fan L, Bao Z, Tu Y, Li C, Chao H, Xu X, Ji J. Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury. Brain Res Bull. 2020;162:84-93.
    CrossRef
25. Tu Q, Li Y, Jin J, Jiang X, Ren Y, He Q. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells. Pharmaceutical Biology. 2019;57(1):778-786.
    CrossRef
26. Ding XQ, Wu WY, Jiao RQ, Gu TT, Xu Q, Pan Y, Kong LD. Curcumin and allopurinol ameliorate fructose-induced hepatic inflammation in rats via miR-200a-mediated TXNIP/NLRP3 inflammasome inhibition. Pharmacol Res. 2018;137:64-75.
    CrossRef
27. Zhang Y, Zeng Y. Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4 /MyD88/NF-κB signal pathway. Drug Development Research. 2019;80(3):353-359.
    CrossRef
28. Panahi Y, Alishiri GH, Parvin S, Sahebkar A. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial. Journal of Dietary Supplements. 2016;13(2):209-220.
    CrossRef
29. Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, Hosseinzadeh-Attar MJ. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. Nutr Metab (Lond). 2019;16:8.
    CrossRef
30. Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian MS, Majeed M, Sahebkar A. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology. 2017;25(1):25-31.
    CrossRef
31. Heshmati J, Moini A, Sepidarkish M, Morvaridzadeh M, Salehi M, Palmowski A, Mojtahedi MF, Shidfar F. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Phytomedicine. 2021;80:153395.
    CrossRef
32. Thota RN, Acharya SH, Garg ML. Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial. Lipids in Health and Disease. 2019;18(1):31.
    CrossRef
33. Adibian M, Hodaei H, Nikpayam O. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Phytother Res. 2019;33(1374):83.
    CrossRef
34. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – A review. J Tradit Complement Med. 2017;7(2):205-233.
    CrossRef
35. Panahi Y, Saberi-Karimian M, Valizadeh O, Behnam B, Saadat A, Jamialahmadi T, Majeed M, Sahebkar A. Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial. Adv Exp Med Biol. 2021;1328:1-9.
    CrossRef
36. Rahimnia AR, Panahi Y, Alishiri G, Sharafi M, Sahebkar A. Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial. Drug Res (Stuttg). 2015;65(10):521-525.
    CrossRef
37. Hejazi J, Rastmanesh R, Taleban FA, Molana SH, Hejazi E, Ehtejab G, Hara N. Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study: Nutrition and Cancer: Vol 68, No 1. December 20, 2022. Accessed December 20, 2022.
    https://www.tandfonline.com/doi/abs/10.1080/01635581.2016.1115527
    CrossRef
38. Mirzabeigi P, Mohammadpour AH, Salarifar M, Gholami K, Mojtahedzadeh M, Javadi MR. The Effect of Curcumin on some of Traditional and Non-traditional Cardiovascular Risk Factors: A Pilot Randomized, Double-blind, Placebo-controlled Trial. Iran J Pharm Res. 2015;14(2):479-486.
39. Lopresti AL, Drummond PD. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. Journal of Affective Disorders. 2017;207:188-196.
    CrossRef
40. Zahedi H, Hosseinzadeh-attar  mohammad javad, shadnoush  mahdi, sahebkar  amirhossein, barkhidarian  bahareh, sadeghi  omid, atabak  najafi, hosseini  saeed, qorbani  mostafa, ahmadi  arezoo, Ardehali  seyed hossein, norouzy  abdolreza. Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double‐blind placebo‐controlled trial – Zahedi – 2021 – Phytotherapy Research – Wiley Online Library. December 20, 2022. Accessed December 20, 2022.
    CrossRef
41. Ried K, Travica N, Dorairaj R, Sali A. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr Res. 2020;76:37-51. doi:10.1016/j.nutres.2020.02.008
    CrossRef
42. Sasongko H, Zulpadly MF, Farida Y. Potential Fish Oil as Acute Hepatitis Candidate by Hepatoprotective Mechanism: A-review. JPSCR: Journal of Pharmaceutical Science and Clinical Research. 2023;8(2):206-217.
    CrossRef
43. Khan H, Ullah H, Nabavi SM. Mechanistic insights of hepatoprotective effects of curcumin: Therapeutic updates and future prospects. Food and Chemical Toxicology. 2019;124:182-191.
    CrossRef
44. Sasongko H, Nugroho AE, Nurrochmad A, Rohman A. Nephroprotective effect of milkfish, patin, and snakehead fish oil by suppressing inflammation and oxidative stress in diabetic rats. Indonesian Journal of Pharmacy. Published online March 25, 2024:63-73.
    CrossRef
45. Salla S, Sunkara R, Ogutu S, Walker LT, Verghese M. Antioxidant activity of papaya seed extracts against H2O2 induced oxidative stress in HepG2 cells. LWT – Food Science and Technology. 2016;66:293-297.
    CrossRef
46. Zheng QT, Yang ZH, Yu LY, Ren YY, Huang QX, Liu Q, Ma XY, Chen ZK, Wang ZB, Zheng X. Synthesis and antioxidant activity of curcumin analogs. J Asian Nat Prod Res. 2017;19(5):489-503.
    CrossRef
47. Alagawany M, Farag MR, Abdelnour SA, Dawood MAO, Elnesr SS, Dhama K. Curcumin and its different forms: A review on fish nutrition. Aquaculture. 2021;532:736030.
    CrossRef
48. Hussain Z, Thu HE, Ng SF, Khan S, Katas H. Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: A review of new trends and state-of-the-art. Colloids Surf B Biointerfaces. 2017;150:223-241.
    CrossRef
49. Frangogiannis NG. The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest. 2017;127(5):1600-1612.
    CrossRef
50. Sasongko H, Qanit WR, W.s RS, S.P.Kristyawan AP, Sugihartini N, Kundarto W, Ermawati DE. Cox-2 inhibition activities of creams containing anguilla bicolor and sea cucumbers extract on croton oil induced inflammation in mice. Pharmaciana. 2020;10(3):281-288.
    CrossRef
51. Kvandova M, Majzúnová M, Dovinová I. The role of PPAR [gamma] in cardiovascular diseases. Physiological research. 2016;65:S343.
    CrossRef
52. Shimizu K, Funamoto M, Sunagawa Y, Shimizu S, Katanasaka Y, Miyazaki Y, Wada H, Hasegawa K, Morimoto T. Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases. Eur Cardiol. 2019;14(2):117-122.
    CrossRef
53. Xu XY, Meng X, Li S, Gan RY, Li Y, Li HB. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients. 2018;10(10):1553.
    CrossRef
54. Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 2014;25(2):144-150.
    CrossRef
55. Shimizu K, Funamoto M, Sunagawa Y, Shimizu S, Katanasaka Y, Miyazaki Y, Wada H, Hasegawa K, Morimoto T. Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases. Eur Cardiol. 2019;14(2):117-122.
    CrossRef